» Articles » PMID: 4607241

The Role of Humoral Antibody in the Rejection of Primary Renal Allografts in Sheep

Overview
Journal J Exp Med
Date 1974 Sep 1
PMID 4607241
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Antibody which had cytotoxic and agglutinating activity against donor lymphocytes appeared in the blood stream of primary renal allograft recipients usually within 48 h of the graft being finally rejected. Appearance of the antibody See PDF for Structure in the blood was associated with severe alterations in vascular permeability and this led to increases in the numbers of red cells and in the protein content of the lymph coming from the allograft. It was possible to elute cytotoxic and agglutinating antibody from renal allograft tissue, showing that this type of antibody was bound to graft antigens during the rejection process. The transfusion of whole serum or serum globulins obtained from sheep that had previously rejected allografts led to the destruction of recently installed renal grafts and the histological changes produced in these grafts and the alterations in the composition of the lymph coming from them were similar to those seen in the terminal stages of primary rejection. These findings have led us to the conclusion that in the sheep, at least the terminal stage of primary renal allograft rejection is mediated by humoral antibody.

Citing Articles

Accommodation in allogeneic and xenogeneic organ transplantation: Prevalence, impact, and implications for monitoring and for therapeutics.

Platt J, Cascalho M Hum Immunol. 2022; 84(1):5-17.

PMID: 36244871 PMC: 10339678. DOI: 10.1016/j.humimm.2022.08.001.


Transplant Tolerance, Not Only Clonal Deletion.

Hall B, Verma N, Tran G, Hodgkinson S Front Immunol. 2022; 13:810798.

PMID: 35529847 PMC: 9069565. DOI: 10.3389/fimmu.2022.810798.


The Role of Major Histocompatibility Complex in Organ Transplantation- Donor Specific Anti-Major Histocompatibility Complex Antibodies Analysis Goes to the Next Stage.

Nakamura T, Shirouzu T, Nakata K, Yoshimura N, Ushigome H Int J Mol Sci. 2019; 20(18).

PMID: 31540289 PMC: 6769817. DOI: 10.3390/ijms20184544.


Specificities of antibodies eluted from human cadaveric renal allografts. Multiple mechanisms of renal allograft injury.

MCPHAUL Jr J, Stastny P, Freeman R J Clin Invest. 1981; 67(5):1405-14.

PMID: 7014636 PMC: 370707. DOI: 10.1172/jci110169.


The immunological significance of cellular infiltrates in chronic rejection of human kidney transplants.

Schluter E, Lennert K, Bohle A Virchows Arch A Pathol Anat Histol. 1975; 368(3):191-204.

PMID: 810952 DOI: 10.1007/BF00432522.


References
1.
Guttmann R, LINDQUIST R, Parker R, Carpenter C, MERRILL J . Renal transplantation in the inbred rat. I. Morphologic, immunologic, and functional alterations during acute rejection. Transplantation. 1967; 5(4):668-81. DOI: 10.1097/00007890-196707000-00010. View

2.
HAMPERS C, KOLKER P, HAGER E . Isolation and characterization of antibodies and other immunologically reactive substances from rejecting renal allografts. J Immunol. 1967; 99(3):514-25. View

3.
Yamada T, KAY J . Kidney homotransplantation with special reference to cytotoxic antibody response. Surgery. 1968; 63(4):637-45. View

4.
Williams G, HUME D, Hudson Jr R, Morris P, Kano K, Milgrom F . "Hyperacute" renal-homograft rejection in man. N Engl J Med. 1968; 279(12):611-8. DOI: 10.1056/NEJM196809192791201. View

5.
Spong F, FELDMAN J, Lee S . Transplantation antibody associated with first-set renal homografts. J Immunol. 1968; 101(3):418-25. View